These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
283 related articles for article (PubMed ID: 25880971)
21. Patients transplanted for nonalcoholic steatohepatitis are at increased risk for postoperative cardiovascular events. Vanwagner LB; Bhave M; Te HS; Feinglass J; Alvarez L; Rinella ME Hepatology; 2012 Nov; 56(5):1741-50. PubMed ID: 22611040 [TBL] [Abstract][Full Text] [Related]
22. Evolution of cardiovascular risk after liver transplantation: a comparison of cyclosporine A and tacrolimus (FK506). Canzanello VJ; Schwartz L; Taler SJ; Textor SC; Wiesner RH; Porayko MK; Krom RA Liver Transpl Surg; 1997 Jan; 3(1):1-9. PubMed ID: 9377752 [TBL] [Abstract][Full Text] [Related]
23. Self-reported oral symptoms and signs in liver transplant recipients and a control population. Helenius-Hietala J; Ruokonen H; Grönroos L; Rissanen H; Suominen L; Isoniemi H; Meurman JH Liver Transpl; 2013 Feb; 19(2):155-63. PubMed ID: 23172817 [TBL] [Abstract][Full Text] [Related]
24. Recurrent or De Novo Allograft Steatosis and Long-term Outcomes After Liver Transplantation. Narayanan P; Mara K; Izzy M; Dierkhising R; Heimbach J; Allen AM; Watt KD Transplantation; 2019 Jan; 103(1):e14-e21. PubMed ID: 29994981 [TBL] [Abstract][Full Text] [Related]
25. Prevalence of cardiovascular risk factors in long-term survivors of childhood cancer: 16 years follow up from a prospective registry. Felicetti F; D'Ascenzo F; Moretti C; Corrias A; Omedè P; Marra WG; Arvat E; Fagioli F; Brignardello E; Gaita F Eur J Prev Cardiol; 2015 Jun; 22(6):762-70. PubMed ID: 24691151 [TBL] [Abstract][Full Text] [Related]
26. The impact of gender and NASH on chronic kidney disease before and after liver transplantation. Fussner LA; Charlton MR; Heimbach JK; Fan C; Dierkhising R; Coss E; Watt KD Liver Int; 2014 Sep; 34(8):1259-66. PubMed ID: 24262002 [TBL] [Abstract][Full Text] [Related]
32. Framingham score, renal dysfunction, and cardiovascular risk in liver transplant patients. Di Maira T; Rubin A; Puchades L; Aguilera V; Vinaixa C; Garcia M; De Maria N; Villa E; Lopez-Andujar R; San Juan F; Montalva E; Perez J; Prieto M; Berenguer M Liver Transpl; 2015 Jun; 21(6):812-22. PubMed ID: 27396823 [TBL] [Abstract][Full Text] [Related]
34. Long-term complications after liver transplantation. Kuramitsu K; Fukumoto T; Iwasaki T; Tominaga M; Matsumoto I; Ajiki T; Ku Y Transplant Proc; 2014 Apr; 46(3):797-803. PubMed ID: 24767352 [TBL] [Abstract][Full Text] [Related]
35. Renal replacement therapy in infants and children with hepatorenal syndrome awaiting liver transplantation: a case-control study. Elizabeth Parsons C; Nelson R; Book LS; Kyle Jensen M Liver Transpl; 2014 Dec; 20(12):1468-74. PubMed ID: 25179803 [TBL] [Abstract][Full Text] [Related]
36. Metabolic syndrome in liver transplant recipients: prevalence, risk factors, and association with cardiovascular events. Laish I; Braun M; Mor E; Sulkes J; Harif Y; Ben Ari Z Liver Transpl; 2011 Jan; 17(1):15-22. PubMed ID: 21254340 [TBL] [Abstract][Full Text] [Related]